JP2005534697A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005534697A5 JP2005534697A5 JP2004526054A JP2004526054A JP2005534697A5 JP 2005534697 A5 JP2005534697 A5 JP 2005534697A5 JP 2004526054 A JP2004526054 A JP 2004526054A JP 2004526054 A JP2004526054 A JP 2004526054A JP 2005534697 A5 JP2005534697 A5 JP 2005534697A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- aggregate
- binding moiety
- target
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 26
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 239000002184 metal Substances 0.000 claims 6
- 229910021645 metal ion Inorganic materials 0.000 claims 5
- 230000005298 paramagnetic effect Effects 0.000 claims 5
- 239000003446 ligand Substances 0.000 claims 4
- 150000001413 amino acids Chemical group 0.000 claims 3
- 238000003384 imaging method Methods 0.000 claims 3
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 239000013522 chelant Substances 0.000 claims 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 claims 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims 2
- HHLZCENAOIROSL-UHFFFAOYSA-N 2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OC(=O)CN1CCNCCN(CC(O)=O)CCN(CC(O)=O)CC1 HHLZCENAOIROSL-UHFFFAOYSA-N 0.000 claims 1
- JHALWMSZGCVVEM-UHFFFAOYSA-N 2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CC1 JHALWMSZGCVVEM-UHFFFAOYSA-N 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- -1 DOTAGA Chemical compound 0.000 claims 1
- 102000004237 Decorin Human genes 0.000 claims 1
- 108090000738 Decorin Proteins 0.000 claims 1
- 102000016942 Elastin Human genes 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- BJAJDJDODCWPNS-UHFFFAOYSA-N dotp Chemical compound O=C1N2CCOC2=NC2=C1SC=C2 BJAJDJDODCWPNS-UHFFFAOYSA-N 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 238000001338 self-assembly Methods 0.000 claims 1
Claims (20)
- 2つ以上の集合ペプチドを含むペプチド凝集体であって、該集合ペプチドのうちの少なくとも1つが金属結合部分を含む、ペプチド凝集体。
- 前記凝集体の流体力学半径が2nmから500nmである、請求項1に記載の凝集体。
- 前記集合ペプチドのうちの少なくとも1つが、標的に対する親和性を有する標的結合部分を含む、請求項1に記載の凝集体。
- 前記標的がHSA、フィブリン、コラーゲン、デコリン、およびエラスチンからなる群より選択される、請求項3に記載の凝集体。
- 前記金属結合部分が有機キレート配位子である、請求項1に記載の凝集体。
- 前記有機キレート配位子がDTPA、DOTA、DOTP、DO3A、DOTAGA、およびNOTAからなる群より選択される、請求項5に記載の凝集体。
- 前記有機キレート配位子が常磁性金属イオンと結合される、請求項5に記載の凝集体。
- 前記常磁性金属イオンがGd(III)である、請求項8に記載の凝集体。
- 前記集合ペプチドが自己集合ペプチドである、請求項1に記載の凝集体。
- 前記配列がC末端で酸性部分によって修飾されている、請求項7に記載の凝集体。
- 前記酸性部分が、直鎖二酸、グルタミン酸、アスパラギン酸、フタル酸、イソフタル酸、およびテレフタル酸からなる群より選択される、請求項11に記載の凝集体。
- 構造P−(C)n有する集合ペプチドであって、Pは集合ペプチドのアミノ酸配列を表し、Cは有機キレート配位子を表し、nは1から10であり得る、集合ペプチド。
- 標的結合部分をさらに含む、請求項13に記載の集合ペプチド。
- 標的結合部分を含む、集合ペプチド。
- EP1272L、EP1593L、EP1594L、EP1595、およびEP1596からなる群より選択される、集合ペプチド。
- 標的をMR画像化するための組成物であって、該組成物は、ペプチド凝集体を含み、該ペプチド凝集体は、常磁性金属イオンと結合した金属結合部分を含む少なくとも1つの集合ペプチドと、該標的に対する親和性を有する標的結合部分を含む少なくとも1つの集合ペプチドとを含む、組成物。
- MR画像化のための組成物であって、該組成物は、ペプチド凝集体を含み、該ペプチド凝集体は常磁性金属イオンと結合した金属結合部分を含む少なくとも1つの集合ペプチドを含む、組成物。
- 標的をMR画像化するための組成物であって、該組成物は、少なくとも2つの集合ペプチドを含み、該少なくとも2つの集合ペプチドは、該患者へ投与された後にペプチド凝集体を作ることが可能であり、該2つの集合ペプチドのうちの少なくとも1つは常磁性金属イオンと結合した金属結合部分を含み、かつ該2つの集合ペプチドのうちの少なくとも1つは該標的に対する親和性を有する標的結合部分を含む、組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40161702P | 2002-08-06 | 2002-08-06 | |
PCT/US2003/024596 WO2004013161A2 (en) | 2002-08-06 | 2003-08-06 | Peptide aggregates |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006210376A Division JP2007008954A (ja) | 2002-08-06 | 2006-08-01 | ペプチド凝集体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005534697A JP2005534697A (ja) | 2005-11-17 |
JP2005534697A5 true JP2005534697A5 (ja) | 2006-09-21 |
Family
ID=31495977
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004526054A Withdrawn JP2005534697A (ja) | 2002-08-06 | 2003-08-06 | ペプチド凝集体 |
JP2006210376A Withdrawn JP2007008954A (ja) | 2002-08-06 | 2006-08-01 | ペプチド凝集体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006210376A Withdrawn JP2007008954A (ja) | 2002-08-06 | 2006-08-01 | ペプチド凝集体 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040204561A1 (ja) |
EP (1) | EP1542709A2 (ja) |
JP (2) | JP2005534697A (ja) |
AU (1) | AU2003261398A1 (ja) |
WO (1) | WO2004013161A2 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ517017A (en) * | 1999-07-29 | 2004-05-28 | Epix Medical Inc | Targeting multimeric imaging agents through multiocus binding and improving the efficacy of in vivo contrast agents |
TWI221406B (en) * | 2001-07-30 | 2004-10-01 | Epix Medical Inc | Systems and methods for targeted magnetic resonance imaging of the vascular system |
AR047692A1 (es) * | 2003-07-10 | 2006-02-08 | Epix Medical Inc | Imagenes de blancos estacionarios |
EP3031466B1 (en) * | 2004-07-06 | 2018-11-28 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
KR20100102750A (ko) | 2005-04-25 | 2010-09-24 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법 |
ES2673947T3 (es) * | 2006-04-25 | 2018-06-26 | Massachusetts Institute Of Technology | Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas |
EP2146733B1 (en) | 2007-03-14 | 2020-11-25 | Arch Biosurgery, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
US20090208421A1 (en) * | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
WO2010041636A1 (ja) | 2008-10-06 | 2010-04-15 | 株式会社スリー・ディー・マトリックス | 組織閉塞剤 |
KR101106433B1 (ko) * | 2009-04-03 | 2012-01-18 | 서울대학교산학협력단 | 암 조직의 타겟팅을 위한 마크로사이클릭 아미노산 계열의 유도체 및 그의 방사성 또는 비방사성 금속 표지화합물 |
WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
JP5855651B2 (ja) * | 2010-07-16 | 2016-02-09 | マサチューセッツ インスティテュート オブ テクノロジー | 改変を組み込んだ自己組織化ペプチドおよびその使用方法 |
US8741833B2 (en) | 2010-07-16 | 2014-06-03 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
US9518105B2 (en) | 2010-12-08 | 2016-12-13 | The Research Foundation For The State University Of New York | Polypeptides derived from calcitonin receptors and methods of use |
WO2012113775A1 (en) | 2011-02-21 | 2012-08-30 | University Of Zurich | Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
EP3466964A1 (en) | 2012-07-06 | 2019-04-10 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
US10383919B1 (en) | 2013-05-31 | 2019-08-20 | The University of the Sciences | Fragments of growth hormone binding protein |
JP6502352B2 (ja) | 2013-08-22 | 2019-04-17 | アーチ・バイオサージェリー・インコーポレイテッド | 流体の移動を制御するための移植可能なメッシュ |
US10245299B2 (en) | 2014-03-10 | 2019-04-02 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary bulla |
WO2015138514A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
US10814038B2 (en) | 2016-01-06 | 2020-10-27 | 3-D Matrix, Ltd. | Combination compositions |
JP2020518673A (ja) | 2017-05-05 | 2020-06-25 | フュージョン・ファーマシューティカルズ・インコーポレイテッド | 二官能性キレートの薬物動態増強及びその使用 |
US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
KR20200004861A (ko) | 2017-05-05 | 2020-01-14 | 퓨전 파마슈티칼즈 인크. | Igf-1r 모노클로날 항체 및 그의 용도 |
US11324703B2 (en) | 2017-12-15 | 2022-05-10 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses thereof in drug delivery |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5439829A (en) * | 1991-01-30 | 1995-08-08 | Eli Lilly And Company | Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5670483A (en) * | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
TWI221406B (en) * | 2001-07-30 | 2004-10-01 | Epix Medical Inc | Systems and methods for targeted magnetic resonance imaging of the vascular system |
-
2003
- 2003-08-06 EP EP03767243A patent/EP1542709A2/en not_active Withdrawn
- 2003-08-06 JP JP2004526054A patent/JP2005534697A/ja not_active Withdrawn
- 2003-08-06 US US10/635,838 patent/US20040204561A1/en not_active Abandoned
- 2003-08-06 WO PCT/US2003/024596 patent/WO2004013161A2/en not_active Application Discontinuation
- 2003-08-06 AU AU2003261398A patent/AU2003261398A1/en not_active Abandoned
-
2006
- 2006-08-01 JP JP2006210376A patent/JP2007008954A/ja not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005534697A5 (ja) | ||
JP2001518523A5 (ja) | ||
JP2008511557A5 (ja) | ||
Kobayashi et al. | Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core | |
Ahrends et al. | Metal-coded affinity tag labeling: a demonstration of analytical robustness and suitability for biological applications | |
JP2005508886A5 (ja) | ||
RU2004122695A (ru) | Мечение галлием-68 и галлием-67 средств для направленной доставки | |
WO2008043822A3 (en) | Amino acid sequences that bind to a desired molecule in a conditional manner | |
EP2540309A3 (en) | Tissue protective peptides and uses thereof | |
WO2004030522A3 (en) | Diagnosis and monitoring of diseases | |
SE508799C2 (sv) | Somatostatinpeptid, förfarande för dess framställning och dess användning | |
JP2007008954A (ja) | ペプチド凝集体 | |
ATE415412T1 (de) | Peptide, die atherosklerotische schädigungen binden | |
JP2011509926A5 (ja) | ||
Firnau | Why do Tc-99m chelates work for cholescintigraphy? | |
Nwe et al. | A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives | |
WO2003066644A1 (fr) | Substance organique liee a une ferrite et son procede de production | |
JP2004517034A (ja) | (神経)ペプチド結合rgd(arg−gly−asp) | |
NO20063106L (no) | MRI-kontrastmediumsammensetning for oral administrasjon | |
JP2011519367A5 (ja) | ||
Langereis et al. | Probing the interaction of the biotin–avidin complex with the relaxivity of biotinylated Gd-DTPA | |
JP2016505514A5 (ja) | ||
JP2003520255A (ja) | 酵素的な切断によって生理活性化される造影剤プロドラッグを使用した磁気共鳴画像法 | |
Caravan et al. | A lysine walk to high relaxivity collagen-targeted MRI contrast agents | |
US20050201943A1 (en) | Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage |